Literature DB >> 18202535

Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.

Takashi Uebanso1, Hidekazu Arai, Yutaka Taketani, Makiko Fukaya, Hironori Yamamoto, Akira Mizuno, Keisuke Uryu, Takahiko Hada, Eiji Takeda.   

Abstract

Momordica charantia (bitter melon) is commonly known as vegetable insulin, but the mechanisms underlying its hypoglycemic effect remain unclear. To address this issue, the effects of bitter melon extracts on postprandial glycemic responses have been investigated in rats. An aqueous extract (AE), methanol fraction (MF) and methanol insoluble fraction (MIF) were prepared from bitter melon. An oral sucrose tolerance test revealed that administration of AE, MF or MIF each significantly suppressed plasma glucose levels at 30 min as compared with the control. In addition, the plasma insulin level at 30 min was also significantly lower after MF administration than in the control in the oral sucrose tolerance test. By contrast, these effects of bitter melon extracts were not observed in the oral glucose tolerance test. In terms of mechanism, bitter melon extracts dose-dependently inhibited the sucrase activity of intestinal mucosa with IC(50) values of 8.3, 3.7 and 12.0 mg/mL for AE, MF and MIF, respectively. The fraction with a molecular weight of less than 1,300 (LT 1,300) obtained from MF inhibited the sucrase activity most strongly in an uncompetitive manner with an IC(50) value of 2.6 mg/mL. Taken together, these results demonstrated that bitter melon suppressed postprandial hyperglycemia by inhibition of alpha-glucosidase activity and that the most beneficial component is present in the LT 1,300 fraction obtained from MF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18202535     DOI: 10.3177/jnsv.53.482

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  19 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  Effects of xylitol on metabolic parameters and visceral fat accumulation.

Authors:  Kikuko Amo; Hidekazu Arai; Takashi Uebanso; Makiko Fukaya; Megumi Koganei; Hajime Sasaki; Hironori Yamamoto; Yutaka Taketani; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2011-06-17       Impact factor: 3.114

3.  Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Authors:  Rooh Ullah Khan; Mohammad Bashir
Journal:  Nutr J       Date:  2015-01-26       Impact factor: 3.271

4.  Glucosidase inhibitory activity and antioxidant activity of flavonoid compound and triterpenoid compound from Agrimonia Pilosa Ledeb.

Authors:  Xi Liu; Liancai Zhu; Jun Tan; Xuemei Zhou; Ling Xiao; Xian Yang; Bochu Wang
Journal:  BMC Complement Altern Med       Date:  2014-01-10       Impact factor: 3.659

5.  Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis.

Authors:  Shin-You Ciou; Cheng-Chin Hsu; Yueh-Hsiung Kuo; Che-Yi Chao
Journal:  Biomedicine (Taipei)       Date:  2014-08-27

6.  Comprehensive Evaluation of Anti-hyperglycemic Activity of Fractionated Momordica charantia Seed Extract in Alloxan-Induced Diabetic Rats.

Authors:  Shailesh Kumar Choudhary; Gagan Chhabra; Dipali Sharma; Aruna Vashishta; Sujata Ohri; Aparna Dixit
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

7.  Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd.

Authors:  Ting-Ni Huang; Kan-Ni Lu; Yi-Ping Pai; Ching-Jang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-26       Impact factor: 2.629

8.  Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches.

Authors:  Temitope Isaac Adelusi; Misbaudeen Abdul-Hammed; Mukhtar Oluwaseun Idris; Oyedele Qudus Kehinde; Ibrahim Damilare Boyenle; Ukachi Chiamaka Divine; Ibrahim Olaide Adedotun; Ajayi Ayodeji Folorunsho; Oladipo Elijah Kolawole
Journal:  In Silico Pharmacol       Date:  2021-06-25

9.  Double emulsion-based mayonnaise encapsulated with bitter gourd extract exhibits improvement in vivo anti-diabetic action in STZ induced rats.

Authors:  Urmila Choudhary; Latha Sabikhi; Suman Kapila
Journal:  3 Biotech       Date:  2021-07-04       Impact factor: 2.893

10.  Hypoglycemic and hypolipidemic activities of aqueous extract of flowers from Nycantus arbor-tristis L. in male mice.

Authors:  Bramanage Sachini Rangika; Pavithra Dilakshini Dayananda; Dinithi Champika Peiris
Journal:  BMC Complement Altern Med       Date:  2015-08-19       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.